Fate Therapeutics Q1 2026 Earnings NarrowerThanExpected Loss Lifts Shares 7 AEIS Q1 2026 Earnings EPS Surpasses Expectations by 35 SPMC Q1 2026 Earnings EPS Misses Estimates Despite Stock Rally RDHL Q2 2022 Earnings Massive EPS Miss Despite No Revenue Stock Rises 481 Q32 Bio Q1 2026 Earnings Narrowed Loss Exceeds Expectations Stock Rises CHH Q1 2026 Earnings EPS Misses Estimates Despite Positive Market Reaction